In 2025, Ivermectin in U.S. health news 2025 continues to capture attention in media and policy debates. As federal vaccine rollbacks take center stage, discussions around ivermectin have intensified, reflecting deeper divisions in healthcare narratives. From media coverage to online communities and congressional inquiries, the drug’s recurring presence highlights the...